Scholarly article on topic 'PReS-FINAL-2196: The clinical significance of the Q703K mutation of NLRP3 gene. A multicentric national study'

PReS-FINAL-2196: The clinical significance of the Q703K mutation of NLRP3 gene. A multicentric national study Academic research paper on "Medical engineering"

0
0
Share paper
Academic journal
Pediatr Rheumatol
OECD Field of science
Keywords
{""}

Academic research paper on topic "PReS-FINAL-2196: The clinical significance of the Q703K mutation of NLRP3 gene. A multicentric national study"

Naselli et al. Pediatric Rheumatology 2013, 11 (Suppl 2):P186

http://www.ped-rheum.com/content/11/S2/P186 * % PEDIATRIC

RHEUMATOLOGY

POSTER PRESENTATION Open Access

PReS-FINAL-2196: The clinical significance of the Q703K mutation of NLRP3 gene. A multicentric national study

A Naselli1*, L Cantarini2, A Insalaco3, M Alessio4, A Tommasini5, R Gallizzi6, S Signa1, OM Lucherini2, F Caroli7, I Ceccherini7, A Martini1, M Gattorno1

From 20th Pediatric Rheumatology European Society (PReS) Congress Ljubljana, Slovenia. 25-29 September 2013

Introduction

The Q703K is a variant of NLRP3 gene has an unknown pathogenetic significance. It, has been considered to be a clinically unremarkable polymorphism, due to its presence in 12-20% of general population. However, a recent study has shown that carriers of the Q703K display an higher secretion of IL-1b, thus suggesting a possible pathogenic role of this variant.

Objectives

To analyse the prevalence of Q703K mutation in patients screened for suspected CAPS and to describe the clinical and biomarkers findings of patients carrying of this mutation.

Methods

From 2002 the molecular analysis of the NLRP3 gene was performed in 615 patients with a clinical history suggestive for CAPS in two different centers (pediatric vs adult). In consideration of the prevalence of this mutation in the general population, 90 healthy individuals were also analyzed for the same mutation.

Results

The Q703K mutation was found in the 35 screened patients (pediatric 17 vs adult 18, with the mean age was 23,7 years, range 3-64). The mean age at onset was 21,5 years (range 0,5-57). Thirty patients were heterozygous for theQ703K mutation only. Two pts displayed other mutations of NLRP3 gene (M604I in one CINCA and D303N and V198M in a MWS). Three patients display

1 Pediatria II, IRCCS, G. Gaslini, Genoa, Italy

Fulllist of author information is available at the end of the article

a monoallelic variant of MEFV gene (R202Q, V726A, D303N). The mean follow-up was 2,5 years (range 0,2-8).

The prevalent clinical features were fever and urticarial rash (23 pts), urticarial rash without fever (6 pts) and periodic fever only (6 pts). The main clinical manifestations and treatment are reported in the table. According to the judgment of the physician in charge, a CAPS-like pheno-type was observed in 23 patients (66%). In 12 pts (34%) an alternative diagnosis was pointed out (mainly undiffer-entiated periodic fever). The frequency of the variant Q703K in normal controls was 2,22%.

Conclusion

The Q703K mutation can be associated to a mild CAPS-like phenotype. Most of the patients do not require anti-ILl treatment and respond satisfactory to steroid

Table 1

Fever and Periodic Urticarial

Urticarial Skin Fever Skin Rash

Rash (6 pts) (6 pts)

(23 pts)

Elevation of acute 22 4 2

phase reactants

Other Symptoms 22 2 3

- Arthralgia 9 0 2

-Transient arthritis 7 1 1

- Conjunctivitis 9 2 1

- Headache 1 0 0

- Mentalretardation 1 1 0

- Dysmorphic bone

Therapy 13 3 5

- Steroids 15 3 3

- NSAIDs 6 0 1

- Anti IL-1 Blockers 10 0 3

- Others

Central

© 2013 Naselli et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Naselli et al. Pediatric Rheumatology 2013, 11(Suppl 2):P186 http://www.ped-rheum.com/content/11/S2/P186

Page 2 of 2

on demand. Even if this variant can be found in patients with a other conditions, the prevalence in patients with CAPS-like phenotype is higher than that detected in healthy controls.

Disclosure of interest

None declared.

Authors' details

1 Pediatria II, IRCCS, G. Gaslini, Genoa, Italy. 2Policlinico Le Scotte, University of Siena, Siena, Italy. 3UO Reumatologia, Ospedale Bambino Gesu, Rome, Italy. 4Dipartimento di Pediatria, Ospedale Federico II, Naples, Italy. 5Dipartimento di Pediatria, IRCCS, B. Garofalo, Trieste, Italy. 6A.O.U. Policlinico G. Martino, Messina, Italy. 7Laboratorio Genetica Molecolare e Citogenetica, IRCCS G. Gaslini, Genoa, Italy.

Published: 5 December 2013

doi:10.1186/1546-0096-11-S2-P186

Cite this article as: Naselli et al: PReS-FINAL-2196: The clinical significance of the Q703K mutation of NLRP3 gene. A multicentric national study. Pediatric Rheumatology 2013 11 (Suppl 2):P186.

Submit your next manuscript to BioMed Central and take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at fpntral

www.biomedcentral.com/submit v-enudi